HEADER HYDROLASE 19-JUN-13 4BTT TITLE FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 31. COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR X LIGHT CHAIN; COMPND 3 CHAIN: A, E; COMPND 4 FRAGMENT: LIGHT CHAIN, RESIDUES 84-179; COMPND 5 SYNONYM: STUART FACTOR, STUART-PROWER FACTOR, FACTOR X LIGHT CHAIN; COMPND 6 EC: 3.4.21.6; COMPND 7 OTHER_DETAILS: DES-GLA DOMAIN; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: COAGULATION FACTOR X; COMPND 10 CHAIN: B, F; COMPND 11 FRAGMENT: HEAVY CHAIN, RESIDUES 235-488; COMPND 12 SYNONYM: STUART FACTOR, STUART-PROWER FACTOR, FACTOR X HEAVY CHAIN; COMPND 13 EC: 3.4.21.6 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: SERUM; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 TISSUE: SERUM KEYWDS HYDROLASE, SAR107375, FACTOR XA INHIBITOR, THROMBIN INHIBITOR, KEYWDS 2 CHLOROTHIOPHENE P1 FRAGMENT, S3 SUBSITE, MICROSOMES STABILITY, ORAL KEYWDS 3 ANTITHROMBOTIC, DUAL INHIBITOR, IV ANTITHROMBOTIC EXPDTA X-RAY DIFFRACTION AUTHOR J.MENEYROL,M.FOLLMANN,G.LASSALLE,V.WEHNER,G.BARRE,T.ROUSSEAUX, AUTHOR 2 J.M.ALTENBURGER,F.PETIT,Z.BOCSKEI,C.STEHLIN-GAON,H.SCHREUDER,N.ALET, AUTHOR 3 J.-P.HERAULT,L.MILLET,F.DOL,C.HASBRAND,P.SCHAEFFER,F.SADOUN, AUTHOR 4 S.KLIEBER,C.BRIOT,F.BONO,J.-M.HERBERT REVDAT 4 01-MAY-24 4BTT 1 REMARK LINK REVDAT 3 08-MAY-19 4BTT 1 REMARK REVDAT 2 15-JAN-14 4BTT 1 JRNL REVDAT 1 18-DEC-13 4BTT 0 JRNL AUTH J.MENEYROL,M.FOLLMANN,G.LASSALLE,V.WEHNER,G.BARRE, JRNL AUTH 2 T.ROUSSEAUX,J.ALTENBURGER,F.PETIT,Z.BOCSKEI,H.SCHREUDER, JRNL AUTH 3 N.ALET,J.HERAULT,L.MILLET,F.DOL,P.FLORIAN,P.SCHAEFFER, JRNL AUTH 4 F.SADOUN,S.KLIEBER,C.BRIOT,F.BONO,J.HERBERT JRNL TITL 5-CHLOROTHIOPHENE-2-CARBOXYLIC ACID JRNL TITL 2 [(S)-2-[2-METHYL-3-(2-OXOPYRROLIDIN-1-YL) JRNL TITL 3 BENZENESULFONYLAMINO]-3-(4-METHYLPIPERAZIN-1-YL) JRNL TITL 4 -3-OXOPROPYL]AMIDE (SAR107375), A SELECTIVE AND POTENT JRNL TITL 5 ORALLY ACTIVE DUAL THROMBIN AND FACTOR XA INHIBITOR. JRNL REF J.MED.CHEM. V. 56 9441 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 24175584 JRNL DOI 10.1021/JM4005835 REMARK 2 REMARK 2 RESOLUTION. 2.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.59 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 18301 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.630 REMARK 3 FREE R VALUE TEST SET COUNT : 848 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.59 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.75 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.73 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2901 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2390 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2746 REMARK 3 BIN R VALUE (WORKING SET) : 0.2359 REMARK 3 BIN FREE R VALUE : 0.2881 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.34 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 155 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4469 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 224 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.82 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.49120 REMARK 3 B22 (A**2) : -3.49120 REMARK 3 B33 (A**2) : 6.98240 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.323 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.312 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.912 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.875 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4705 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6367 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1642 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 122 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 681 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4705 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 3 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 597 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 4 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4997 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.95 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 1.64 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.56 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: EGF-1 DOMAIN IS DISORDERED REMARK 4 REMARK 4 4BTT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-JUN-13. REMARK 100 THE DEPOSITION ID IS D_1290057333. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87260 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18301 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.590 REMARK 200 RESOLUTION RANGE LOW (A) : 48.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.59 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.25000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: IN-HOUSE FACTOR XA STRUCTURE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 8 MG/ML DESGLA REMARK 280 FACTOR XA, 5 MM MES (PH 6.0), 5 MM CACL2, 100 MM BENZAMIDINE. REMARK 280 RESERVOIR SOLUTION: 18-20% PEG600, 50 MM MES (PH 5.7). HANGING REMARK 280 DROP SETUP., VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 116.96000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 58.48000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2620 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A -41 REMARK 465 LYS A -40 REMARK 465 ASP A -39 REMARK 465 GLY A -38 REMARK 465 ASP A -37 REMARK 465 GLN A -36 REMARK 465 CYS A -35 REMARK 465 GLU A -34 REMARK 465 THR A -33 REMARK 465 SER A -32 REMARK 465 PRO A -31 REMARK 465 CYS A -30 REMARK 465 GLN A -29 REMARK 465 ASN A -28 REMARK 465 GLN A -27 REMARK 465 GLY A -26 REMARK 465 LYS A -25 REMARK 465 CYS A -24 REMARK 465 LYS A -23 REMARK 465 ASP A -22 REMARK 465 GLY A -21 REMARK 465 LEU A -20 REMARK 465 GLY A -19 REMARK 465 GLU A -18 REMARK 465 TYR A -17 REMARK 465 THR A -16 REMARK 465 CYS A -15 REMARK 465 THR A -14 REMARK 465 CYS A -13 REMARK 465 LEU A -12 REMARK 465 GLU A -11 REMARK 465 GLY A -10 REMARK 465 PHE A -9 REMARK 465 GLU A -8 REMARK 465 GLY A -7 REMARK 465 LYS A -6 REMARK 465 ASN A -5 REMARK 465 CYS A -4 REMARK 465 GLU A -3 REMARK 465 LEU A -2 REMARK 465 PHE A -1 REMARK 465 THR A 0 REMARK 465 LEU A 49 REMARK 465 GLU A 50 REMARK 465 ARG A 51 REMARK 465 GLY B 246 REMARK 465 LEU B 247 REMARK 465 PRO B 248 REMARK 465 LYS B 249 REMARK 465 ALA B 250 REMARK 465 LYS B 251 REMARK 465 SER B 252 REMARK 465 HIS B 253 REMARK 465 ALA B 254 REMARK 465 PRO B 255 REMARK 465 GLU B 256 REMARK 465 VAL B 257 REMARK 465 ILE B 258 REMARK 465 THR B 259 REMARK 465 SER B 260 REMARK 465 SER B 261 REMARK 465 PRO B 262 REMARK 465 LEU B 263 REMARK 465 LYS B 264 REMARK 465 TYR E -41 REMARK 465 LYS E -40 REMARK 465 ASP E -39 REMARK 465 GLY E -38 REMARK 465 ASP E -37 REMARK 465 GLN E -36 REMARK 465 CYS E -35 REMARK 465 GLU E -34 REMARK 465 THR E -33 REMARK 465 SER E -32 REMARK 465 PRO E -31 REMARK 465 CYS E -30 REMARK 465 GLN E -29 REMARK 465 ASN E -28 REMARK 465 GLN E -27 REMARK 465 GLY E -26 REMARK 465 LYS E -25 REMARK 465 CYS E -24 REMARK 465 LYS E -23 REMARK 465 ASP E -22 REMARK 465 GLY E -21 REMARK 465 LEU E -20 REMARK 465 GLY E -19 REMARK 465 GLU E -18 REMARK 465 TYR E -17 REMARK 465 THR E -16 REMARK 465 CYS E -15 REMARK 465 THR E -14 REMARK 465 CYS E -13 REMARK 465 LEU E -12 REMARK 465 GLU E -11 REMARK 465 GLY E -10 REMARK 465 PHE E -9 REMARK 465 GLU E -8 REMARK 465 GLY E -7 REMARK 465 LYS E -6 REMARK 465 ASN E -5 REMARK 465 CYS E -4 REMARK 465 GLU E -3 REMARK 465 LEU E -2 REMARK 465 PHE E -1 REMARK 465 THR E 0 REMARK 465 ARG E 1A REMARK 465 GLY F 246 REMARK 465 LEU F 247 REMARK 465 PRO F 248 REMARK 465 LYS F 249 REMARK 465 ALA F 250 REMARK 465 LYS F 251 REMARK 465 SER F 252 REMARK 465 HIS F 253 REMARK 465 ALA F 254 REMARK 465 PRO F 255 REMARK 465 GLU F 256 REMARK 465 VAL F 257 REMARK 465 ILE F 258 REMARK 465 THR F 259 REMARK 465 SER F 260 REMARK 465 SER F 261 REMARK 465 PRO F 262 REMARK 465 LEU F 263 REMARK 465 LYS F 264 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 245 CA C O CB CG CD NE REMARK 470 ARG B 245 CZ NH1 NH2 REMARK 470 ARG E 51 CA C O CB CG CD NE REMARK 470 ARG E 51 CZ NH1 NH2 REMARK 470 ARG F 245 CA C O CB CG CD NE REMARK 470 ARG F 245 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 1B -32.00 65.88 REMARK 500 GLN A 10 -114.59 -119.39 REMARK 500 GLN A 16 -108.10 66.33 REMARK 500 ASN A 17 -1.06 61.42 REMARK 500 SER A 18 -159.62 -131.10 REMARK 500 SER A 18 -159.62 -151.88 REMARK 500 TYR A 42 70.26 62.58 REMARK 500 ASP B 24 107.74 -57.30 REMARK 500 ASN B 38 -16.60 68.36 REMARK 500 GLU B 86 -63.61 -92.78 REMARK 500 LYS B 204 -97.92 67.21 REMARK 500 SER B 214 -83.04 -109.31 REMARK 500 MET B 242 30.01 -84.63 REMARK 500 LEU E 1C -108.66 57.09 REMARK 500 GLN E 10 -113.93 -123.02 REMARK 500 ASN E 17 155.98 66.25 REMARK 500 SER E 18 128.18 70.78 REMARK 500 LYS E 34 -50.28 -137.35 REMARK 500 ASP F 24 108.87 -59.30 REMARK 500 ARG F 115 -154.52 -147.27 REMARK 500 LYS F 204 -88.12 67.37 REMARK 500 ASP F 205 12.06 -142.31 REMARK 500 SER F 214 -80.02 -109.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH F2080 DISTANCE = 6.74 ANGSTROMS REMARK 525 HOH F2081 DISTANCE = 6.45 ANGSTROMS REMARK 525 HOH F2082 DISTANCE = 9.42 ANGSTROMS REMARK 525 HOH F2084 DISTANCE = 6.25 ANGSTROMS REMARK 525 HOH F2085 DISTANCE = 8.30 ANGSTROMS REMARK 525 HOH F2086 DISTANCE = 7.77 ANGSTROMS REMARK 525 HOH F2087 DISTANCE = 5.85 ANGSTROMS REMARK 525 HOH F2088 DISTANCE = 7.94 ANGSTROMS REMARK 525 HOH F2089 DISTANCE = 9.25 ANGSTROMS REMARK 525 HOH F2090 DISTANCE = 6.26 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B1245 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 70 OD1 REMARK 620 2 ASN B 72 O 85.0 REMARK 620 3 GLN B 75 O 130.4 68.9 REMARK 620 4 GLU B 77 OE1 120.4 94.9 103.8 REMARK 620 5 GLU B 77 OE2 98.4 138.0 129.3 47.4 REMARK 620 6 GLU B 80 OE2 76.3 130.6 89.3 134.0 90.3 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA F1245 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP F 70 OD1 REMARK 620 2 ASN F 72 O 82.4 REMARK 620 3 GLN F 75 O 146.4 68.6 REMARK 620 4 GLU F 80 OE2 93.5 131.4 93.2 REMARK 620 5 GLU F 80 OE1 79.6 161.9 129.2 52.8 REMARK 620 6 HOH F2022 O 108.2 104.6 95.6 122.4 79.0 REMARK 620 N 1 2 3 4 5 REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "BB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "FB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 1245 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA F 1245 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VYR B 1246 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VYR F 1246 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4BTI RELATED DB: PDB REMARK 900 FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 58. REMARK 900 RELATED ID: 4BTU RELATED DB: PDB REMARK 900 FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 57. REMARK 999 REMARK 999 SEQUENCE REMARK 999 ACTIVATED FORM REMARK 999 GLA DOMAIN REMOVED WITH CHYMOTRYPSIN DBREF 4BTT A -41 51 UNP P00742 FA10_HUMAN 84 179 DBREF 4BTT B 16 264 UNP P00742 FA10_HUMAN 235 488 DBREF 4BTT E -41 51 UNP P00742 FA10_HUMAN 84 179 DBREF 4BTT F 16 264 UNP P00742 FA10_HUMAN 235 488 SEQRES 1 A 96 TYR LYS ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN SEQRES 2 A 96 ASN GLN GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR SEQRES 3 A 96 CYS THR CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU SEQRES 4 A 96 LEU PHE THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP SEQRES 5 A 96 CYS ASP GLN PHE CYS HIS GLU GLU GLN ASN SER VAL VAL SEQRES 6 A 96 CYS SER CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY SEQRES 7 A 96 LYS ALA CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS SEQRES 8 A 96 GLN THR LEU GLU ARG SEQRES 1 B 254 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 B 254 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 B 254 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 B 254 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 B 254 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY SEQRES 6 B 254 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 B 254 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 B 254 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 B 254 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 B 254 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 B 254 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU SEQRES 12 B 254 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 B 254 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 B 254 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 B 254 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 B 254 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 B 254 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 B 254 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 19 B 254 ARG GLY LEU PRO LYS ALA LYS SER HIS ALA PRO GLU VAL SEQRES 20 B 254 ILE THR SER SER PRO LEU LYS SEQRES 1 E 96 TYR LYS ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN SEQRES 2 E 96 ASN GLN GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR SEQRES 3 E 96 CYS THR CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU SEQRES 4 E 96 LEU PHE THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP SEQRES 5 E 96 CYS ASP GLN PHE CYS HIS GLU GLU GLN ASN SER VAL VAL SEQRES 6 E 96 CYS SER CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY SEQRES 7 E 96 LYS ALA CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS SEQRES 8 E 96 GLN THR LEU GLU ARG SEQRES 1 F 254 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 F 254 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 F 254 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 F 254 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 F 254 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY SEQRES 6 F 254 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 F 254 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 F 254 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 F 254 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 F 254 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 F 254 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU SEQRES 12 F 254 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 F 254 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 F 254 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 F 254 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 F 254 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 F 254 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 F 254 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 19 F 254 ARG GLY LEU PRO LYS ALA LYS SER HIS ALA PRO GLU VAL SEQRES 20 F 254 ILE THR SER SER PRO LEU LYS HET CA B1245 1 HET VYR B1246 42 HET CA F1245 1 HET VYR F1246 42 HETNAM CA CALCIUM ION HETNAM VYR N-[(S)-1-[5-(5-CHLORO-THIOPHEN-2-YL)-ISOXAZOL-3- HETNAM 2 VYR YLMETHYL]-2-(4-METHOXY-PIPERIDIN-1-YL)-2-OXO-ETHYL]-2- HETNAM 3 VYR ETHYL-3-(3-OXO-MORPHOLIN-4-YL)-BENZENESULFONAMIDE FORMUL 5 CA 2(CA 2+) FORMUL 6 VYR 2(C28 H33 CL N4 O7 S2) FORMUL 9 HOH *224(H2 O) HELIX 1 1 LEU A 3 CYS A 8 5 6 HELIX 2 2 ALA B 55 GLN B 61 5 7 HELIX 3 3 GLU B 124A THR B 131 1 8 HELIX 4 4 ASP B 164 SER B 172 1 9 HELIX 5 5 PHE B 234 MET B 242 1 9 HELIX 6 6 LEU E 3 CYS E 8 5 6 HELIX 7 7 ALA F 55 GLN F 61 5 7 HELIX 8 8 GLU F 124A THR F 131 1 8 HELIX 9 9 ASP F 164 SER F 172 1 9 HELIX 10 10 PHE F 234 MET F 242 1 9 SHEET 1 AA 2 PHE A 11 GLU A 15 0 SHEET 2 AA 2 SER A 18 SER A 22 -1 O SER A 18 N GLU A 15 SHEET 1 AB 2 TYR A 27 LEU A 29 0 SHEET 2 AB 2 CYS A 36 PRO A 38 -1 O ILE A 37 N THR A 28 SHEET 1 BA 7 GLN B 20 GLU B 21 0 SHEET 2 BA 7 LYS B 156 PRO B 161 -1 O MET B 157 N GLN B 20 SHEET 3 BA 7 THR B 135 GLY B 140 -1 O GLY B 136 N VAL B 160 SHEET 4 BA 7 PRO B 198 PHE B 203 -1 O PRO B 198 N SER B 139 SHEET 5 BA 7 THR B 206 TRP B 215 -1 O THR B 206 N PHE B 203 SHEET 6 BA 7 GLY B 226 LYS B 230 -1 O ILE B 227 N SER B 214 SHEET 7 BA 7 MET B 180 ALA B 183 -1 O PHE B 181 N TYR B 228 SHEET 1 BB 7 GLN B 30 ASN B 35 0 SHEET 2 BB 7 GLY B 40 ILE B 46 -1 N PHE B 41 O LEU B 33 SHEET 3 BB 7 TYR B 51 THR B 54 -1 O LEU B 53 N THR B 45 SHEET 4 BB 7 ALA B 104 LEU B 108 -1 O ALA B 104 N THR B 54 SHEET 5 BB 7 ALA B 81 LYS B 90 -1 N GLU B 86 O ARG B 107 SHEET 6 BB 7 PHE B 64 VAL B 68 -1 O PHE B 64 N VAL B 85 SHEET 7 BB 7 GLN B 30 ASN B 35 -1 O LEU B 32 N ARG B 67 SHEET 1 EA 2 PHE E 11 GLU E 14 0 SHEET 2 EA 2 VAL E 19 SER E 22 -1 O VAL E 20 N HIS E 13 SHEET 1 EB 2 TYR E 27 LEU E 29 0 SHEET 2 EB 2 CYS E 36 PRO E 38 -1 O ILE E 37 N THR E 28 SHEET 1 FA 7 GLN F 20 GLU F 21 0 SHEET 2 FA 7 LYS F 156 PRO F 161 -1 O MET F 157 N GLN F 20 SHEET 3 FA 7 THR F 135 GLY F 140 -1 O GLY F 136 N VAL F 160 SHEET 4 FA 7 PRO F 198 PHE F 203 -1 O PRO F 198 N SER F 139 SHEET 5 FA 7 THR F 206 TRP F 215 -1 O THR F 206 N PHE F 203 SHEET 6 FA 7 GLY F 226 LYS F 230 -1 O ILE F 227 N SER F 214 SHEET 7 FA 7 MET F 180 ALA F 183 -1 O PHE F 181 N TYR F 228 SHEET 1 FB 7 GLN F 30 ILE F 34 0 SHEET 2 FB 7 GLY F 40 ILE F 46 -1 N PHE F 41 O LEU F 33 SHEET 3 FB 7 TYR F 51 THR F 54 -1 O LEU F 53 N THR F 45 SHEET 4 FB 7 ALA F 104 LEU F 108 -1 O ALA F 104 N THR F 54 SHEET 5 FB 7 ALA F 81 LYS F 90 -1 N GLU F 86 O ARG F 107 SHEET 6 FB 7 LYS F 65 VAL F 68 -1 O VAL F 66 N HIS F 83 SHEET 7 FB 7 GLN F 30 ILE F 34 -1 O LEU F 32 N ARG F 67 SSBOND 1 CYS A 1 CYS A 12 1555 1555 2.04 SSBOND 2 CYS A 8 CYS A 21 1555 1555 2.03 SSBOND 3 CYS A 23 CYS A 36 1555 1555 2.03 SSBOND 4 CYS A 44 CYS B 122 1555 1555 2.04 SSBOND 5 CYS B 22 CYS B 27 1555 1555 2.04 SSBOND 6 CYS B 42 CYS B 58 1555 1555 2.03 SSBOND 7 CYS B 168 CYS B 182 1555 1555 2.03 SSBOND 8 CYS B 191 CYS B 220 1555 1555 2.04 SSBOND 9 CYS E 1 CYS E 12 1555 1555 2.04 SSBOND 10 CYS E 8 CYS E 21 1555 1555 2.03 SSBOND 11 CYS E 23 CYS E 36 1555 1555 2.03 SSBOND 12 CYS E 44 CYS F 122 1555 1555 2.04 SSBOND 13 CYS F 22 CYS F 27 1555 1555 2.04 SSBOND 14 CYS F 42 CYS F 58 1555 1555 2.03 SSBOND 15 CYS F 168 CYS F 182 1555 1555 2.03 SSBOND 16 CYS F 191 CYS F 220 1555 1555 2.04 LINK OD1 ASP B 70 CA CA B1245 1555 1555 2.29 LINK O ASN B 72 CA CA B1245 1555 1555 2.16 LINK O GLN B 75 CA CA B1245 1555 1555 2.85 LINK OE1 GLU B 77 CA CA B1245 1555 1555 2.63 LINK OE2 GLU B 77 CA CA B1245 1555 1555 2.83 LINK OE2 GLU B 80 CA CA B1245 1555 1555 2.57 LINK OD1 ASP F 70 CA CA F1245 1555 1555 2.32 LINK O ASN F 72 CA CA F1245 1555 1555 2.15 LINK O GLN F 75 CA CA F1245 1555 1555 2.97 LINK OE2 GLU F 80 CA CA F1245 1555 1555 2.15 LINK OE1 GLU F 80 CA CA F1245 1555 1555 2.69 LINK CA CA F1245 O HOH F2022 1555 1555 2.76 CISPEP 1 LYS F 62 ARG F 63 0 2.57 SITE 1 AC1 5 ASP B 70 ASN B 72 GLN B 75 GLU B 77 SITE 2 AC1 5 GLU B 80 SITE 1 AC2 5 ASP F 70 ASN F 72 GLN F 75 GLU F 80 SITE 2 AC2 5 HOH F2022 SITE 1 AC3 16 HIS B 57 GLN B 61 THR B 98 TYR B 99 SITE 2 AC3 16 PHE B 174 ALA B 190 CYS B 191 GLN B 192 SITE 3 AC3 16 VAL B 213 SER B 214 TRP B 215 GLY B 216 SITE 4 AC3 16 GLY B 226 TYR B 228 HOH B2082 ASN F 92 SITE 1 AC4 15 GLN F 61 GLU F 97 THR F 98 TYR F 99 SITE 2 AC4 15 PHE F 174 ALA F 190 CYS F 191 GLN F 192 SITE 3 AC4 15 VAL F 213 SER F 214 TRP F 215 GLY F 216 SITE 4 AC4 15 GLY F 226 TYR F 228 HOH F2074 CRYST1 56.210 56.210 175.440 90.00 90.00 120.00 P 32 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017790 0.010271 0.000000 0.00000 SCALE2 0.000000 0.020543 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005700 0.00000